FDA committee recommends cannabis-based drug By Green Cross on April 20, 2018 in MMJ Info Federal advisers voted Thursday to recommend approval of the first prescription cannabidiol medicine — to treat rare and severe forms of epilepsy. Read more »
Comments are closed.